RARB (Retinoic Acid Receptor Beta) plays a critical role in cell differentiation and growth inhibition, while CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A) is a tumor suppressor involved in cell cycle regulation. This evidence concerns the gene CDKN2A and neoplasm.